Processa Pharmaceuticals, Inc. (PCSA) stock
PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.73+0.01 (+0.58%)
Close on Nov 17, 2026Market cap $4.83MP/E –Yield –
Processa Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Processa Pharmaceuticals's revenue for the twelve months ending Sep 30, 2023 was $0. For fiscal 2022 it was $0. The highest annual figure on record is $312.48K in fiscal 2013.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $0 | – |
| FY2021 | Dec 31, 2021 | $0 | -100.0% |
| FY2016 | Dec 31, 2016 | $5.00K | -95.6% |
| FY2015 | Dec 31, 2015 | $113.43K | +5.8% |
| FY2014 | Dec 31, 2014 | $107.24K | -65.7% |
| FY2013 | Dec 31, 2013 | $312.48K | +62.6% |
| FY2012 | Dec 31, 2012 | $192.15K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2023 | Sep 30, 2023 | $0 | – |
| Q2 FY2023 | Jun 30, 2023 | $0 | – |
| Q1 FY2023 | Mar 31, 2023 | $0 | – |
| Q4 FY2022 | Dec 31, 2022 | $0 | – |
| Q3 FY2022 | Sep 30, 2022 | $0 | – |
| Q2 FY2022 | Jun 30, 2022 | $0 | – |
| Q1 FY2022 | Mar 31, 2022 | $0 | – |
| Q4 FY2021 | Dec 31, 2021 | $0 | – |
| Q3 FY2021 | Sep 30, 2021 | $0 | -100.0% |
| Q4 FY2016 | Dec 31, 2016 | $0 | – |
| Q3 FY2016 | Sep 30, 2016 | $0 | – |
| Q2 FY2016 | Jun 30, 2016 | $0 | – |
| Q1 FY2016 | Mar 31, 2016 | $5.00K | – |
See a number that looks wrong?